Surveillance for Pancreatic Cancer in High-Risk Individuals Leads to Improved Outcomes: A Propensity Score-Matched Analysis

倾向得分匹配 胰腺癌 医学 内科学 肿瘤科 癌症
作者
Derk C.F. Klatte,Bas Boekestijn,Anke Onnekink,Friedo W. Dekker,Lydia G. van der Geest,Martin N.J.M. Wasser,Shirin Feshtali,J. Sven D. Mieog,Saskia Luelmo,Hans Morreau,Thomas P. Potjer,Akin Inderson,Jurjen J. Boonstra,Hans F. A. Vasen,Jeanin E. van Hooft,Bert A. Bonsing,Monique E. van Leerdam
出处
期刊:Gastroenterology [Elsevier BV]
卷期号:164 (7): 1223-1231.e4 被引量:69
标识
DOI:10.1053/j.gastro.2023.02.032
摘要

BACKGROUND & AIMS: Recent pancreatic cancer surveillance programs of high-risk individuals have reported improved outcomes. This study assessed to what extent outcomes of pancreatic ductal adenocarcinoma (PDAC) in patients with a CDKN2A/p16 pathogenic variant diagnosed under surveillance are better as compared with patients with PDAC diagnosed outside surveillance. METHODS: In a propensity score matched cohort using data from the Netherlands Cancer Registry, we compared resectability, stage, and survival between patients diagnosed under surveillance with non-surveillance patients with PDAC. Survival analyses were adjusted for potential effects of lead time. RESULTS: Between January 2000 and December 2020, 43,762 patients with PDAC were identified from the Netherlands Cancer Registry. Thirty-one patients with PDAC under surveillance were matched in a 1:5 ratio with 155 non-surveillance patients based on age at diagnosis, sex, year of diagnosis, and tumor location. Outside surveillance, 5.8% of the patients had stage I cancer, as compared with 38.7% of surveillance patients with PDAC (odds ratio [OR], 0.09; 95% confidence interval [CI], 0.04-0.19). In total, 18.7% of non-surveillance patients vs 71.0% of surveillance patients underwent a surgical resection (OR, 10.62; 95% CI, 4.56-26.63). Patients in surveillance had a better prognosis, reflected by a 5-year survival of 32.4% and a median overall survival of 26.8 months vs 4.3% 5-year survival and 5.2 months median overall survival in non-surveillance patients (hazard ratio, 0.31; 95% CI 0.19-0.50). For all adjusted lead times, survival remained significantly longer in surveillance patients than in non-surveillance patients. CONCLUSION: Surveillance for PDAC in carriers of a CDKN2A/p16 pathogenic variant results in earlier detection, increased resectability, and improved survival as compared with non-surveillance patients with PDAC.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
充电宝的应助被MADAO采纳,获得30
1秒前
上官若男的应助被青小泥采纳,获得10
1秒前
xing发布了新的文献求助10
1秒前
万能图书馆的应助被左白易采纳,获得10
2秒前
OS完成签到 ,获得积分10
2秒前
2秒前
陈晓钱完成签到,获得积分10
4秒前
4秒前
5秒前
xiaoxia完成签到,获得积分10
5秒前
DUMPLINGS完成签到 ,获得积分10
6秒前
6秒前
hnu完成签到,获得积分20
6秒前
充电宝的应助被suzy采纳,获得10
8秒前
盛龙完成签到,获得积分10
8秒前
lky1017完成签到,获得积分10
10秒前
shjddw完成签到,获得积分10
11秒前
情怀的应助被栗子砸采纳,获得10
11秒前
Lucas的应助被XPR采纳,获得10
12秒前
13秒前
orixero的应助被xiaoxia采纳,获得100
13秒前
14秒前
14秒前
yinxinyi发布了新的文献求助40
14秒前
14秒前
14秒前
15秒前
阿伯茨的完成签到,获得积分10
16秒前
shuyiWang发布了新的文献求助10
16秒前
Susuna完成签到 ,获得积分10
17秒前
木头发布了新的文献求助10
17秒前
18秒前
19秒前
时尚的紫蓝完成签到,获得积分10
20秒前
20秒前
yhr发布了新的文献求助10
21秒前
哭泣的凝芙完成签到,获得积分10
21秒前
22秒前
22秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181839
求助须知:如何正确求助?哪些是违规求助? 9571537
关于积分的说明 21818552
捐赠科研通 7778091
什么是DOI,文献DOI怎么找? 3433524
关于科研通互助平台的介绍 2557696
邀请新用户注册赠送积分活动 2479621